Another insurance company continues to rate the WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program as excellent. Highmark Blue Cross Blue Shield in West Virginia recently notified the program that it has received the company’s Blue Distinction Centers for Transplants Designation, which denotes commitment to delivering quality specialty care safely, effectively and cost efficiently. This marks the second consecutive time the Cancer Institute has received the designation from Highmark. “This validates that our program continues to provide superior care,” Sonia Leadmon, oncology quality coordinator at the Cancer Institute Mary Babb Randolph Cancer Center, said.
The health insurer took into consideration patient volume, transplant quality outcomes and additional accreditations the program has previoulsly received from other agencies.
The Council for Women's Concerns is accepting nominations for the Mary Catherine Buswell Award. This accolade, established in 1978, honors a person who has shown a dedication to the advancement of women. The award winner will receive $500 for travel, supplies, salary supplement or any other use commensurate with WVU policies. Nominations must be submitted by March 1.
The WVU Cancer Institute is joining organizations across the world to increase awareness of cervical cancer this January in recognition of Cervical Cancer Awareness Month. Cervical cancer diagnoses have increased the last 40 years as the result of many women getting regular Pap tests, which can find cervical precancerous cells before they become cancer.